Brief: Exact Therapeutics Presents Clinical Case Report Data At Science & Technology Event
March 28 (Reuters) - Exact Therapeutics AS EXTX.OL :
* PRESENTS ENCOURAGING CLINICAL CASE REPORT DATA AT SCIENCE
&
TECHNOLOGY EVENT
* PRESENTS DATA FROM TWO PATIENTS WITH LIVER METASTASES OF
COLORECTAL CANCER ORIGIN TREATED WITH ACT I
* RESULTS FROM THESE TWO PATIENTS SUGGEST AN IMPROVED
RESPONSE TO
STANDARD OF CARE CHEMOTHERAPY IN TUMOURS THAT ARE EXPOSED TO ACT
TREATMENT
Source text for Eikon: ID:nObiBpxwka
Further company coverage: EXTX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Exact Therapeutics AS
See all newsBrief: EXACT Therapeutics AS Gets Positive Safety Review For 60 Μl/Kg Dose In Phase 2 ENACT Trial
Brief: Exact Therapeutics Introduces New Long-Term Incentive Program
Brief: Exact Therapeutics H1 Operating Loss Widens To NOK 45.9 Million
Brief: Exact Therapeutics Announces Grant Of Core Patent In U.S.
Brief: Exact Therapeutics Announces Final Positive Data From Phase 1 Trial